The FDA announced Breakthrough Therapy Designation (BTD) for acalabrutinib (Calquence) as a single agent to treat chronic lymphocytic leukemia (CLL)
The Daily Breeze has captured Stan Kurtz’ amazing swim in this article that you can read here!
Related posts
